Refer A Patient

Request An Appointment

Neurology

SOLIRIS

SOLIRIS (eculizumab) is a monoclonal antibody that binds to proteins in the blood that can destroy red blood cells.
Infusion or injection therapy referral
What it treats Myasthenia Gravis (in patients who are acetyl-choline receptor antibody positive), Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS)
Prescribed by Neurologists
How it’s administered Intravenous (IV) infusion
Frequency Every other week
Length of treatment About 45 minutes

About This Therapy

SOLIRIS (eculizumab) is a monoclonal antibody that binds to proteins in the blood that can destroy red blood cells. Specifically, it is a complement inhibitor antibody used to treat myasthenia gravis and certain hemolytic (blood-related) syndromes.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

SOLIRIS REFERRAL FORM

SOLIRIS REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.
REFERRAL FORM →

Ready to refer a patient for SOLIRIS

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.